CCL2 and polycystic ovary syndrome: Notably, in this model, hyperhomocysteinemia leads to elevations in TNF-α, IL-6, and MCP-1 and exaggerates insulin resistance (85), risk factors for cardiovascular diseases observed in PCOS.